Fluoxetine augmentation of clozapine treatment in patients with schizophrenia

American Journal of Psychiatry

Volumn 153, Issue 12, 1996, Pages 1625-1627

  Buchanan, Robert W ^a,b   Kirkpatrick, Brian ^a   Bryant, Nancy ^a   Ball, Patricia ^a   Breier, Alan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUOXETINE; HALOPERIDOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 0029903904     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.12.1625     Document Type: Article

References (12)

1. Buchanan RW: Clozapine: efficacy and safety. Schizophr Bull 1995; 21:579-591
2. Silver H, Nassar A: Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study. Biol Psychiatry 1992; 31:698-704
3. Goldman MB, Janecek HM: Adjunctive fluoxetine improves global function in chronic schizophrenia. J Neuropsychiatry 1990; 2:429-431
4. Goff DC, Brotman AW, Waites M, McCormick S: Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients. Am J Psychiatry 1990; 147:492-494
5. Goff DC, Midha KK, Sarid-Segal O, Hubbard JW, Amico E: A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology (Berl) 1995; 117:417-423
6. Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994; 151:20-26
7. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
8. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
9. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, Md, US Department of Health, Education, and Welfare, 1976, pp 217-222
10. Breier A: Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 1995; 14:187-202
11. Eggert AE, Crismon MI., Dorson PG: Lack of effect of fluoxetine on plasma clozapine concentrations (letter). J Clin Psychiatry 1994; 55:454-455
12. Centorrino F, Baldessarini RJ, Kando J, Frankenburg FR, Volpicelli SA, Puopolo PR, Flood JG: Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry 1994; 151:123-125